A 24-year-old man who appears to have type 1 diabetes tweeted a video saying he had just graduated from college and was now waiting to die as the price of insulin and other diabetic supplies used to keep him alive each day had skyrocketed to $2,000 a month, the National Archives reported Thursday. It turns out that the first thing Joe Biden signed after taking office was the “Memo: Regulatory Review” executive action that froze regulatory changes made by Trump, including lowering the cost of insulin and epinephrine.
The man said, “I was 24 years old, fresh out of college before the outbreak, and not making much money. I don’t know what I can do to pay $2,000 a month to keep me alive.”
The man said indignantly, “America is so unbelievable that I can’t even live. I guess I’m just waiting to die.”
It is unlikely that the man’s insulin and pump costs would have reached such astronomical figures during President Trump’s tenure. President Trump specifically signed four executive orders last July aimed at reducing the cost of such drugs. He directed the Secretary of health and Human Services to “end the middleman shadow rebate system that has led to high drug costs that many Americans have to face.”
President Trump said that the use of insulin and epinephrine pens (EpiPens) in emergencies can combat severe and fatal allergic reactions, but that the high cost of these drugs has prevented low-income people who “desperately” need them from receiving treatment.
The executive order also includes a directive that requires federal community health centers to give patients direct access to the significant discounts they receive from pharmaceutical companies on insulin and epinephrine pens.
Biden has never explained why he is rescinding the Trump Executive Order, which is designed to help poor Americans. Many conservatives believe it will fuel dissatisfaction with the current health care system and pave the way for the socialization of alternative Medicine.
Recent Comments